Despite fervent objection from diabetes patients and advocates, European drugmakers Novo Nordisk and Sanofi have raised the prices of insulin in the U.S., according to the Financial Times.
Pharmacy
After more than 30 drugmakers ushered in the new year with a wave of price hikes, another pharma giant, Johnson & Johnson, is following suit.
Biosimilars are reshaping the treatment landscape for biologic-based therapies. In addition to producing clinically-equivalent outcomes to their reference products, studies show biosimilars will contribute to lowering the overall cost of healthcare1.
Pfizer will lay off 1,700 employees and cease manufacturing "immediately" at two plants in India, according to The Hindu Business Line.
Drugmaker Lupin Somerset is recalling 23,460 bottles of Nitrofurantoin, an oral antibiotic used for the treatment and prevention of bladder infections, according to The Economic Times.
Advertisement
Pharma giant AstraZeneca plans to shut down operations in two Colorado cities, which will result in 210 employees losing their jobs, according to the Boulder Daily Camera.
Healthcare and government officials are growing concerned that biologic makers are using scare tactics to prevent generic versions of their products from entering or succeeding in the market, according to The Washington Post.
Thirteen pharmacy leaders and companies were honored by the American Pharmacists Association for their contributions to the field in 2019.
As Congress returned this week, several lawmakers rushed to introduce bills aimed at lowering the price Americans pay for prescription drugs, according to STAT.
At a private dinner hosted by JPMorgan Chase Chairman and CEO Jamie Dimon with pharma executives this week before the bank's San Francisco healthcare conference, Amazon was a hot topic of conversation, but Mr. Dimon revealed little about the goals…